Literature DB >> 22811490

VEGF165b overexpression restores normal glomerular water permeability in VEGF164-overexpressing adult mice.

Sebastian Oltean1, Christopher R Neal, Athina Mavrou, Panisha Patel, Thomas Ahad, Chloe Alsop, Thomas Lee, Karen Sison, Yan Qiu, Steven J Harper, David O Bates, Andrew H J Salmon.   

Abstract

Vascular endothelial growth factor (VEGF)-A, a family of differentially spliced proteins produced by glomerular podocytes, maintains glomerular filtration barrier function. The expression of VEGF molecules is altered in human nephropathy. We aimed to determine the roles of the angiogenic VEGF(164) isoform, and the antiangiogenic VEGF(165)b isoform in mature, adult glomeruli in vivo using conditional, inducible transgenic overexpression systems in mice. Podocyte-specific VEGF(164) overexpression (up to 100 days) was induced by oral administration of doxycycline to adult podocin-rtTA/TetO-VEGF(164) double transgenic mice. The consequences of simultaneous overexpression of VEGF(164) and VEGF(165)b were assessed in triple-transgenic podocin-rtTA/TetO-VEGF(164)/nephrin-VEGF(165)b mice. Persistent VEGF(164) overexpression did not cause proteinuria but did increase glomerular ultrafiltration coefficient between days 3 and 7. Despite persistently increased VEGF(164) levels, glomerular ultrafiltration coefficient normalized by day 14 and remained normal up to 100 days. Decreased subpodocyte space (SPS) coverage of the glomerular capillary wall accompanied increased glomerular hydraulic conductivity in VEGF(164)-overexpressing mice. The changes in glomerular ultrafiltration coefficient and SPS coverage induced by 7 days of overexpression of VEGF(164) were not present in triple transgenic VEGF(164) and VEGF(165)b overexpressing mice. These results indicate that 1) the adult mouse glomerulus is relatively resistant to induced VEGF(164) overexpression. VEGF(164) overexpression altered glomerular permeability but did not cause proteinuria in these mature, adult animals; 2) the SPS is a dynamic VEGF-responsive modulator of glomerular function; and 3) the balance of VEGF isoforms plays a critical role in the regulation of glomerular permeability. VEGF(165)b is capable of preventing VEGF(164)-induced changes in glomerular permeability and ultrastructure in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22811490      PMCID: PMC3469682          DOI: 10.1152/ajprenal.00410.2011

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  40 in total

Review 1.  Structural determinants of glomerular permeability.

Authors:  W M Deen; M J Lazzara; B D Myers
Journal:  Am J Physiol Renal Physiol       Date:  2001-10

Review 2.  Properties of the glomerular barrier and mechanisms of proteinuria.

Authors:  Börje Haraldsson; Jenny Nyström; William M Deen
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

3.  Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes.

Authors:  D Veron; C A Bertuccio; A Marlier; K Reidy; A M Garcia; J Jimenez; H Velazquez; M Kashgarian; G W Moeckel; A Tufro
Journal:  Diabetologia       Date:  2011-02-12       Impact factor: 10.122

4.  The anti-angiogenic VEGF isoform VEGF165b transiently increases hydraulic conductivity, probably through VEGF receptor 1 in vivo.

Authors:  C A Glass; S J Harper; D O Bates
Journal:  J Physiol       Date:  2006-01-19       Impact factor: 5.182

5.  Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome.

Authors:  Valérie Anne Schumacher; Stefanie Jeruschke; Frank Eitner; Jan Ulrich Becker; Gerald Pitschke; Yasemin Ince; Jeffrey H Miner; Ivo Leuschner; Rainer Engers; Anne Schulze Everding; Monika Bulla; Brigitte Royer-Pokora
Journal:  J Am Soc Nephrol       Date:  2007-01-31       Impact factor: 10.121

6.  Vascular endothelial growth factor increases the ultrafiltration coefficient in isolated intact Wistar rat glomeruli.

Authors:  Andrew H J Salmon; Christopher R Neal; David O Bates; Steven J Harper
Journal:  J Physiol       Date:  2005-10-20       Impact factor: 5.182

Review 7.  Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy.

Authors:  Fuad N Ziyadeh
Journal:  Diabetes Res Clin Pract       Date:  2008-10-07       Impact factor: 5.602

8.  Morphometric analysis of effects of angiotensin II on glomerular structure in rats.

Authors:  M E Pagtalunan; R Rasch; H G Rennke; T W Meyer
Journal:  Am J Physiol       Date:  1995-01

9.  Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome.

Authors:  M Kestilä; U Lenkkeri; M Männikkö; J Lamerdin; P McCready; H Putaala; V Ruotsalainen; T Morita; M Nissinen; R Herva; C E Kashtan; L Peltonen; C Holmberg; A Olsen; K Tryggvason
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

Review 10.  Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease.

Authors:  Takahiko Nakagawa
Journal:  Am J Physiol Renal Physiol       Date:  2007-06
View more
  12 in total

1.  Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy.

Authors:  Sebastian Oltean; Yan Qiu; Joanne K Ferguson; Megan Stevens; Chris Neal; Amy Russell; Amit Kaura; Kenton P Arkill; Kirstie Harris; Clare Symonds; Katja Lacey; Lihini Wijeyaratne; Melissa Gammons; Emma Wylie; Richard P Hulse; Chloe Alsop; George Cope; Gopinath Damodaran; Kai B Betteridge; Raina Ramnath; Simon C Satchell; Rebecca R Foster; Kurt Ballmer-Hofer; Lucy F Donaldson; Jonathan Barratt; Hans J Baelde; Steven J Harper; David O Bates; Andrew H J Salmon
Journal:  J Am Soc Nephrol       Date:  2014-12-26       Impact factor: 10.121

Review 2.  The role of VEGF 165b in pathophysiology.

Authors:  Maria Peiris-Pagès
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

3.  Effect of Melilotus suaveolens extract on pulmonary microvascular permeability by downregulating vascular endothelial growth factor expression in rats with sepsis.

Authors:  Ming-Wei Liu; Mei-Xian Su; Wei Zhang; Yun Hui Wang; Lan-Fang Qin; Xu Liu; Mao-Li Tian; Chuan-Yun Qian
Journal:  Mol Med Rep       Date:  2015-01-07       Impact factor: 2.952

4.  Resolution of the three dimensional structure of components of the glomerular filtration barrier.

Authors:  Kenton P Arkill; Klaus Qvortrup; Tobias Starborg; Judith M Mantell; Carlo Knupp; C Charles Michel; Steve J Harper; Andy H J Salmon; John M Squire; Dave O Bates; Chris R Neal
Journal:  BMC Nephrol       Date:  2014-02-01       Impact factor: 2.388

5.  VEGF-A165 b protects against proteinuria in a mouse model with progressive depletion of all endogenous VEGF-A splice isoforms from the kidney.

Authors:  Megan Stevens; Christopher R Neal; Andrew H J Salmon; David O Bates; Steven J Harper; Sebastian Oltean
Journal:  J Physiol       Date:  2017-07-03       Impact factor: 5.182

Review 6.  Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease.

Authors:  Megan Stevens; Sebastian Oltean
Journal:  Genes (Basel)       Date:  2018-02-15       Impact factor: 4.096

7.  Vascular Endothelial Growth Factor-A165b Restores Normal Glomerular Water Permeability in a Diphtheria-Toxin Mouse Model of Glomerular Injury.

Authors:  Megan Stevens; Christopher R Neal; Andrew H J Salmon; David O Bates; Steven J Harper; Sebastian Oltean
Journal:  Nephron       Date:  2018-01-26       Impact factor: 2.847

8.  Assessment of Kidney Function in Mouse Models of Glomerular Disease.

Authors:  Megan Stevens; Sebastian Oltean
Journal:  J Vis Exp       Date:  2018-06-30       Impact factor: 1.355

9.  Role of the eNOS-NO system in regulating the antiproteinuric effects of VEGF receptor 2 inhibition in diabetes.

Authors:  Andrew Advani; Kim A Connelly; Suzanne L Advani; Kerri Thai; Yuan Zhang; Darren J Kelly; Richard E Gilbert
Journal:  Biomed Res Int       Date:  2013-08-22       Impact factor: 3.411

Review 10.  Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression.

Authors:  Katsuyuki Tanabe; Yasufumi Sato; Jun Wada
Journal:  Int J Mol Sci       Date:  2018-06-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.